Xu Wenfeng

Chief Pharmacist, MD Supervisor

Research Interests: drug quality and safety evaluation

Tel: +86-010-85133621

Email: xuwenfenghill@126.com

EDUCATION

Doctor of Science, Shenyang Pharmaceutical University (2014)

Bachelor of Science, Shenyang Pharmaceutical University (2009)

PROFESSIONAL EXPERIENCE

2014.8–present  Beijing Hospital, Department of Pharmacy

• 2021.2–present  Director of Drug QC Department

• 2024.7–present  Chief pharmacist

• 2019.8–2024.6  Associate chief pharmacist

• 2015.8–2019.7  Pharmacist-in-charge

• 2014.8–2015.7  Junior pharmacist

ACADEMIC APPOINTMENTS

2025.6–2029.6     Chinese Pharmaceutical Association, Committee of popularization of science, Youth Member

2024.9–2029.9     Chinese Pharmacological Society, Committee of therapeutic drug monitoring, Youth Member

2022.8–2027.8     Chinese Medicine Education Association, Committee of Geriatric Pharmacy, Member

2021.7–present     Beijing Pharmaceutical Association, Committee of Pharmaceutics, Member

2021.7–present     Beijing Pharmaceutical Association, Committee of Pharmaceutical Analysis, Member

2025.5–2027.5      Editorial committee of Drugs and Clinic, Youth Member

2025.4–2029.4      Editorial committee of Central South Pharmacy, Youth Member

2024.12–2027.12  Editorial committee of China Pharmaceuticals, Youth Member

2023.7–2027.7      Editorial committee of Clinical Medication Journal, Youth Member

AWARDS AND CERTIFICATES

Outstanding Reviewer, Periodical Office of Central South Pharmacy (2025)

Outstanding Youth Member of Editorial committee, Periodical Office of Central South Pharmacy (2023)

Outstanding Pharmacist, Beijing Pharmaceutical Association (2020)

REPRESENTATIVE PUBLICATIONS

1. Wang Y^#, Xu W^#, Guo S, Xu S, Wang J, Zhang S, Kuang Y, Jin P. Enterococci for human health: a friend or foe? Microbial Pathogenesis, 2025, 201: 107381. (SCIE, Q2, IF-2024=3.5)

2. Zhu Y, Zhao F, Zhu Y, Li X, Dong D, Zhu B, Li J, Hu X, Zhao Z, Xu W, Jv Y, Wang D, Zheng Y, Dong Y, Li L, Yang S, Teng Z, Lu L, Zhu J, Du L, Liu Y, Jia L, Zhang Q, Ma H, Zhao A, Jiang H, Xu X, Wang J, Qian X, Zhang W, Zheng T, Yang C, Chen X, Liu K, Jiang H, Qu D, Song J, Cheng H, Sun W, Zhan H, Li X, Wang Y, Wang A, Liu L, Yang L, Zhang N, Chen S, Ma J, Liu W, Du X, Zheng M, Wan L, Du G, Liu H, Jin P. Real-world efficacy and safety of azvudine in hospitalized older patients with COVID-19 during the omicron wave in China: A retrospective cohort study. Acta Pharmaceutica Sinica B, 2025, 15(1): 123-132. (SCIE, Q1, IF-2024=14.6)

3. Yu H, Chen Q, Xu TC, Wang Y, Xu WF, Li M, Zhang X, Zhao C, Zhang DL, Jin PF, Li SY, Tang SA. Bioactive terpenoids and sterols from the fruiting bodies of Fomitopsis pinicola. Phytochemistry, 2025, 236: 114510. (SCIE, Q1, IF-2024=3.4)

4. Jin P, Lin X, Xu W, Li K, Zhao X, Guo S, Zhao Z, Jiang L, Liao F, Chang L, Wang M, Liu Y, Huang S, Chen Z, Ji F. The feasibility of using pathobiome strains as live biotherapeutic products for human use. Imeta, 2024, 3: e202. (SCIE, Q1, IF-2024=33.2)

5. Xu W, Xu S, Kuang Y, He X, Jin P. Compatibility of Niuhuang Jiedu Tablets results in attenuated arsenic bioaccumulation and consequent protection against realgar-induced toxicity in mice. Evidence-Based Complementary and Alternative Medicine, 2022, 2022: 7406694. (SCIE, Q3, IF-2021=2.65)